CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 141 filers reported holding CLOVIS ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $385,000 | -12.7% | 66,000 | +1.0% | 0.01% | -23.1% |
Q2 2020 | $441,000 | +58.6% | 65,334 | +49.7% | 0.01% | +18.2% |
Q1 2020 | $278,000 | -60.8% | 43,633 | -35.8% | 0.01% | -8.3% |
Q4 2019 | $709,000 | +178.0% | 68,000 | +4.6% | 0.01% | +140.0% |
Q3 2019 | $255,000 | -75.5% | 65,000 | -7.1% | 0.01% | -82.1% |
Q2 2019 | $1,041,000 | -23.8% | 70,000 | +27.3% | 0.03% | -17.6% |
Q1 2019 | $1,366,000 | +280.5% | 55,000 | +175.0% | 0.03% | +126.7% |
Q4 2018 | $359,000 | -42.5% | 20,000 | -5.8% | 0.02% | -6.2% |
Q3 2018 | $624,000 | -35.1% | 21,231 | +0.4% | 0.02% | -30.4% |
Q2 2018 | $961,000 | -5.7% | 21,139 | +9.5% | 0.02% | -28.1% |
Q1 2018 | $1,019,000 | -40.1% | 19,300 | -22.8% | 0.03% | -27.3% |
Q4 2017 | $1,700,000 | -31.2% | 25,000 | -16.7% | 0.04% | -52.2% |
Q3 2017 | $2,472,000 | +55.3% | 30,000 | +76.5% | 0.09% | +37.3% |
Q2 2017 | $1,592,000 | +13.6% | 17,000 | -22.7% | 0.07% | +19.6% |
Q1 2017 | $1,401,000 | +277.6% | 22,000 | +340.0% | 0.06% | +250.0% |
Q1 2015 | $371,000 | -33.8% | 5,000 | -50.0% | 0.02% | -15.8% |
Q4 2014 | $560,000 | -17.6% | 10,000 | -33.3% | 0.02% | +11.8% |
Q3 2014 | $680,000 | – | 15,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |